Until is a moonshot company building a “pause button” for biology. Our near-term focus is organ-scale reversible cryopreservation: preserving donated organs at subzero temperatures without ice formation, then rewarming them uniformly for transplant. By solving this grand challenge, we're laying the foundation for whole-body reversible cryopreservation, giving patients a bridge to future cures.
To achieve our goal, we are assembling an interdisciplinary team to develop perfusion systems, cryoprotectant formulations, and vitrification and rewarming hardware.
We envision a future where no transplantable organ is lost to logistics, and no terminal diagnosis is final because patients can safely wait for future medicine to arrive.
We are seeking a Scientist/Senior Scientist to join our team. In this role, you will play a crucial role in advancing cryopreservation formulations by designing, executing, and analyzing high-throughput experiments across multiple biological scales, including cells, 3D in‑vitro models, and tissues. Experience with primary cell culture and tissues (Kidney, Liver, Heart, etc.) is strongly preferred.
Depending on experience, you may also lead projects, mentor junior team members, and take on greater responsibility for experimental design and strategy. This position requires a balance of technical expertise and creative problem-solving to uncover novel materials, explore biomaterial–biology interactions, and develop innovative biological mechanisms to enhance performance.
As an equal opportunity employer, Until is committed to providing employment opportunities to all individuals. All applicants for positions at Until will be treated without regard to race, color, ethnicity, religion, sex, gender, gender identity and expression, sexual orientation, national origin, disability, age, marital status, veteran status, pregnancy, or any other basis prohibited by applicable law.
While this represents our expected range based on market data, final compensation will be determined based on your specific qualifications and may be outside this range. Please keep in mind that the equity portion of the offer is not included in this estimate.